GlobeNewswire by notified

Columbus A/S Annual Report 2022


Company announcement no. 2/2023

2022 financial performance: Investment in organic growth

Columbus continued to grow revenue, which amounted to DKK 1,389m in 2022, corresponding to an increase of 9%. EBITDA increased by 3% to DKK 91.8m.

All major Business Lines and most Market Units contributed to the revenue growth, especially the strategic Business Lines Digital commerce, Data & Analytics and Customer Experience & Engagement delivered solid growth.

“We are satisfied with our results in 2022 delivering yet another year with organic growth. Our stronger position with larger customers and strengthened organization are the results of our focused growth strategy - but we also recognize that profitability must be improved in 2023”, says Chairman of the Board, Ib Kunøe

“Industry focus has truly proven its value and by the end of 2022 74% of our customers originated from our core industries. In 2023, we will also be selective in our new sales activities to further position Columbus as a trusted advisor for larger customers looking for integrity, proven track record and high levels of industry-specific expertise”, says CEO & President, Søren Krogh Knudsen.

Performance highlights 2022

  • Revenue growth of 9% amounting to DKK 1,389m
  • EBITDA amounted to DKK 91.8m
  • Recurring revenue amounted to DKK 192m, corresponding to an increase of 8%
  • Profit after tax amounted to DKK 30m
  • Efficiency of 63%

Operational highlights 2022

  • Our new CFO Brian Iversen joined Columbus
  • Divestment of Russian subsidiary
  • Launch of global customer development program
  • Improved efficiency in the Global Delivery Center in India
  • Merge of Project and Care Business Lines
  • Strengthening the Digital Advisory focus
  • Launch of new sustainability strategy
  • Continued focus on One-Columbus culture

Service revenue split on Business Lines

DKK ´00020222021∆%
Digital Commerce192,233157,18422.3%
Data & Analytics59,33237,67657.5%
Customer Experience & Engagement45,17930,00850.6%
Strategy & Change6,5130100.0%
Other Local Business64,69968,798-6.0%
Total sale of services1,317,0421,210,2918.8%
Total sale of products 72,39268,8935.1%
Total net revenue1,389,4341,279,1848.6%

Service revenue split on Market Units

DKK ´00020222021∆%
Total sale of services1,317,0421,210,2918.8%
Total sale of products 72,39268,8935.1%
Total net revenue1,389,4341,279,1848.6%

Outlook for 2023
In 2023 we expect organic growth close to or above 10% and earnings improvements through enhanced efficiency and focus on contract profitability. Our full year guidance for 2023 is as follows:

  • Revenue expected to be in the range of DKK 1,500m – 1,550m, corresponding to a growth of 8-12%
  • EBITDA is expected to be in the range of DKK 115m – 135m corresponding to a margin of 7.4% - 9.0%.

In Q4 2023, we will launch our new strategy with long-term operational og financial goals.

For full details, see attached Annual Report 2022.

Live webcast and conference call
Columbus is hosting a live webcast and conference call on 15 March 2023 at 13:00 CET. The webcast is hosted by CEO & President Søren Krogh Knudsen and Group CFO Brian Iversen.

Webcast: Please log in to the webcast via Columbus’ investor site where you can follow the presentation and submit your written questions during the call:

Conference call:

1. Participants are required to register in advance of the conference using the link provided below. Upon registering, each participant will be provided with Participant Dial In Numbers, and a unique Personal PIN.

2. In the 10 minutes prior to call start time, Participants will need to use the conference access information provided in the e-mail received at the point of registering. Participants may also use the call me feature instead of dialling the nearest dial in number.

Online Registration to the call:

For further information, please contact:

  • Søren Krogh Knudsen, CEO & President, Tel.: +45 7020 5000
  • Tine Rasmussen, Communication Director,, Tel.: +45 2969 0677

About Columbus 
Columbus is a global IT services and consulting company specialized in digital transformation. Our more than 1,550+ digital explorers collaborate with our customers in the manufacturing, retail & distribution, and food & process industries. We advise, implement and manage business critical solutions within Strategy & Change, Customer Experience, Digital Commerce, Data & Analytics, Application Management and Cloud ERP. Headquartered in Denmark, we have offices and partners worldwide - delivering locally on a global Columbus A/S is listed on Nasdaq Copenhagen – COLUM

For more information visit


To view this piece of content from, please give your consent at the top of this page.
To view this piece of content from, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Oxurion Publishes 2022 Annual Report31.3.2023 20:42:16 CEST | Press release

Regulated Information Leuven, BELGIUM,Boston, MA, US–March 31, 2023– 07.00 PM CET – Oxurion NV (Euronext Brussels: OXUR) a biopharmaceutical company developing next generation standard of care ophthalmic therapies, with clinical stage assets in vascular retinal disorders, published its annual report for the financial year 2022. The annual report for the year ending December 31, 2022 is available in the “Investors” section of the Company’s website, and can also be downloaded as a PDF. About Oxurion Oxurion (Euronext Brussels: OXUR) is a biopharmaceutical company developing next generation standard of care ophthalmic therapies, which are designed to improve and better preserve vision in patients with retinal disorders including diabetic macular edema (DME), the leading cause of vision loss in working-age people, as well as other conditions. Oxurion intends to play an important role in the treatment of retinal disorders, including the successful development of THR-149, its novel therapeut

Nokia Corporation: Repurchase of own shares on 31.03.202331.3.2023 20:00:00 CEST | Press release

Nokia Corporation Stock Exchange Release 31 March 2023 at 21:00 EEST Nokia Corporation: Repurchase of own shares on 31.03.2023 Espoo, Finland – On 31 March 2023 Nokia Corporation (LEI: 549300A0JPRWG1KI7U06) has acquired its own shares (ISIN FI0009000681) as follows: Trading venue (MIC Code)Number of sharesWeighted average price / share, EUR*XHEL221,1864.49CEUX21,0654.50AQEU12,3894.49TQEX7,3604.50Total262,0004.49 * Rounded to two decimals On 3 February 2022, Nokia announced that its Board of Directors is initiating a share buyback program under the authorization granted by Nokia’s Annual General Meeting on 8 April 2021 to return up to EUR 600 million of cash to shareholders in tranches over a period of two years. The second phase of the share buyback program in compliance with the Market Abuse Regulation (EU) 596/2014 (MAR), the Commission Delegated Regulation (EU) 2016/1052 and under the authorization granted by Nokia’s Annual General Meeting on 5 April 2022 started on 2 January 2023 a

Fly Play hf.: Amendments to share option plan31.3.2023 20:00:00 CEST | Press release

Amendments to share option plan As detailed in the Company Description in relation to the listing of shares in Fly Play hf. on Nasdaq First North Iceland, dated June 2021, the Company had, in accordance with the remuneration then in force, implemented a share-based incentive program in the form of option rights whereby the Company granted several members of the management team and other key employees options to purchase shares in the Company as part of their remuneration. Having regard for the purposes of the share-based incentive program referred to above, the Board of Directors has decided to extend the exercise period in relation to share options to purchase a total of 16.666.669 shares in the Company, at a purchase price of ISK 8 per share. For a period of 12 months, these options are therefore exercisable until April 2024, at which point the options expire. The options may be exercised at any time during the exercise period.

SBM Offshore completes US$1.63 billion financing of Almirante Tamandaré31.3.2023 19:25:15 CEST | Press release

March 31, 2023 SBM Offshore is pleased to announce it has signed the project financing of FPSO Almirante Tamandaré for a total of US$1.63 billion. The project financing is provided by a consortium of 13 international banks with insurance cover from 4 international Export Credit Agencies (ECA). The financing is composed of five separate facilities with a ca. 6.3% weighted average cost of debt and a 14-year post-completion maturity for both the ECA covered facilities and the uncovered facility. The FPSO’s design incorporates SBM Offshore’s industry leading Fast4Ward® new build, multi-purpose hull. It will be the largest oil producing unit in Brazil with a processing capacity of 225,000 barrels of oil and 12 million m3 of gas per day. The FPSO will have an estimated greenhouse gas (GHG) emission intensity below 10 kgCO2e/boe1 and will benefit from emission reduction technologies such as the closed flare technology which increases gas utilization, preventing it from being burnt into the at